ACT logo

AlzChem Group Stock Price

Symbol: XTRA:ACTMarket Cap: €1.4bCategory: Materials

ACT Share Price Performance

ACT Community Fair Values

Recent ACT News & Updates

No updates

AlzChem Group AG Key Details

€559.8m

Revenue

€208.0m

Cost of Revenue

€351.8m

Gross Profit

€295.3m

Other Expenses

€56.5m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
5.56
Gross Margin
62.84%
Net Profit Margin
10.09%
Debt/Equity Ratio
0%

AlzChem Group AG Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About ACT

Founded
1908
Employees
1647
CEO
Andreas Niedermaier
WebsiteView website
www.alzchem.com

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silicon nitride for ceramics; and photovoltaic modules in the solar industry. The Basics & Intermediates segment produces raw materials for specialty chemicals; and products for agriculture and metallurgy, as well as intermediates for the chemical industry that are produced from lime, carbon, and electricity. This segment also engages in the production and sale of guanidine salts as a raw material for agrochemicals and active pharmaceutical ingredients. The Other & Holding segment provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. It offers products and services to agricultural sector under the CALCIUM CYANAMIDE PERLKA, EMINEX, DORMEX, ALZOGUR, SITOFEX, and BREAK-THRU brands; animal nutrition sector under the CREAMINO brands; human nutrition sector under the CREAPURE, CREAVITALIS, LIVADUR, and ALIPURE brands; pharma sector under the GUANIDINE SALTS – BIOSELECT brand; fine chemicals sector under the GUANIDINSALZE -BIOSELECT, CYANAMIDE, DICYANDIAMIDE, GUANAMINE, NITRILES, MELFLOCK and ALZOFIX, THIOUREA, and NITROGUANIDINE brands; metallurgy sector under the CAD, CALCIPRO, and CALZOT brands, as well as technical gases and calcium carbide; renewable energy sector under the DYHARD and SILZOT brands; and custom synthesis, such as toll micronization and manufacturing. The company was founded in 1908 and is based in Trostberg, Germany.

German Market Performance

  • 7 Days: 1.0%
  • 3 Months: 4.3%
  • 1 Year: 18.7%
  • Year to Date: 13.9%
The market is up 1.0% over the last week, with the Industrials sector leading the way, up 2.4%. In contrast, the Information Technology sector is lagging, dropping 3.8%. In the last year, the market has climbed 19%. Earnings are forecast to grow by 16% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading